Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

2.
8.
10.
12.

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, Poole PH.

Neurology. 2000 Jan 11;54(1):156-63.

PMID:
10636142
13.

Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study.

Akpunonu BE, Mutgi AB, Federman DJ, Volinsky FG, Brickman K, Davis RL, Gilbert C, Asgharnejad M.

Ann Emerg Med. 1995 Apr;25(4):464-9. Erratum in: Ann Emerg Med 1995 Jun;25(6):857.

PMID:
7710149
14.
15.

A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.

Savani N, Brautaset NJ, Reunanen M, Szirmai I, Ashford EA, Hassani H, Saiers J.

Int J Clin Pract Suppl. 1999 Aug;105:7-15.

PMID:
10692717
16.

Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice.

Scott RJ, Aitchison WR, Barker PR, McLaren GI.

QJM. 1996 Aug;89(8):613-22.

PMID:
8935482
18.

Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.

Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.

Headache. 2006 Jan;46(1):115-24.

PMID:
16412159
19.

Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.

Thomson AN, Arthur GP, Bergin PS, Pollock M, Parkin PJ, Flanagan M, Samson SA.

N Z Med J. 1993 May 12;106(955):171-3.

PMID:
8389026
20.

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.

Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD.

Arch Neurol. 1996 Nov;53(11):1132-7.

PMID:
8912486

Supplemental Content

Support Center